Found 6 matching trials
Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated With Gene-Modified Cells
N/AThe goal of this clinical study is to learn more about the long-term safety...
Status
Enrolling By Invitation
Location
Banner MD Anderson Cancer Center
A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple Myeloma
PHASE3The goal of this study (iMMagine-3) is to compare the study drug, anitocabt...
Status
Active Not Recruiting
Location
Banner MD Anderson Cancer Center
Efficacy and Safety of Anitocabtagene Autoleucel in Participants With Newly Diagnosed Multiple Myeloma (GEM-AnitoFIRST)
PHASE2The goal of this clinical trial is to learn if anitocabtagene autoleucel fo...
Location
Hospital Germans Trias i Pujol (ICO BADALONA)
Study of Anitocabtagene-autoleucel in Relapsed or Refractory Multiple Myeloma (iMMagine-1)
PHASE2A Phase II study of anitocabtagene-autoleucel (formerly CART-ddBCMA) for pa...
Status
Active Not Recruiting
Location
HonorHealth Cancer Transplant Institute
A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
PHASE1A Phase 1 dose-escalation study designed to evaluate the safety, tolerabili...
Location
UCLA Medical Center
Study of Anitocabtagene-autoleucel in Participants With Relapsed Refractory Multiple Myeloma
PHASE1Master protocol for cell therapy, Phase 1 proof-of-concept studies in relap...
Status
Active Not Recruiting
Location
Advanced Cellular Therapeutics Facility, DCAM 0800A